Boston, MA 06/13/2013 (wallstreetpr) – The share prices of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) had surged by 8.37 percent to close at $2.08 per share for the end of last trading session. The stock opened at $2.24 and made an intraday high of $2.31 before plunging sharply. Over 83.56m shares were traded in the last trading session.
ZIOPHARM Oncology Inc.(NASDAQ:ZIOP) is at present trading at $2.08 per share, seeing a fall of 8.59% (-$0.19) from its last closing price of $2.27 per share. The share price is trading 15.43% above its 50-day simple moving average, while it is 3.72% above its 20-day simple moving average. The company posts a healthy current ratio of 2.97, pointing towards its ability to effectively deal with short-term debt. It shows that the company has carried out its working capital management efficiently. It has a market capitalization of $174.23 million against 83.56 million outstanding shares. Insider ownership of shares in the company stands at 1.85%, while 51.63% of the shares are institutionally held. The mean value of the recommendations given by analysts about the stock is 3.00 (where 1=buy; 3=hold; 5=sell).
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) rose 4.61% to $2.27 on volume of 1.38M shares versus average-daily volume of 1.69M shares, completely recovering from fall on its presentation of updated results from Ad-RTS-IL-12 Phase I study in advanced melanoma at the 2013 ASCO Annual Meeting. After last close, its performance in 2013 stands at -45.43%.
Ziopharm Oncology Inc (NASDAQ:ZIOP) is reporting the departure of Jason A. Amello, the Company’s Executive Vice President and CFO and Treasurer, beginning May 31, 2013, due to the ongoing rationalization and overhauling of its business operations. Shares of the company tumbled over 6% on Tuesday.
With a recent loss of -6.83%, to $1.91, the share price of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) has moved down from its 20 days moving average -0.10% and negatively from its 50 days moving average -0.01%. ZIOPHARM Oncology Inc (NASDAQ:ZIOP): In Monday’s trading session, shares of ZIOPHARM Oncology Inc (NASDAQ:ZIOP) dipped by 5.96%. The opening price of the shares was $2.26 which reached an intraday high of $2.28 before dropping to $2.05 per share. In excess of 1.82M shares exchanged hands in the trading session on Monday. This number was higher than the average volume of 1.63M that was measured over 30-day period.